gas pain glp 1 Flatulence from GLP-1 Injections gas semaglutide Ozempic (semaglutide) is
Description
Weight loss itself, a primary outcome of GLP-1 therapy, is associated with improved blood flow and reduced clotting tendency
Biocon will handle regulatory approval, manufacturing, and supply, while Medix will manage commercialization in Mexico
Preclinical studies provide mixed evidence
However, the impact of this conjugate on blood glucose in diabetic patients will also be closely monitored, as GIP antagonists may even worsen diabetes
GLP-1
